Zimmer Biomet (NYSE:ZBH) has reportedly reached a settlement with plaintiffs in a case over allegedly defective NexGen knee implants, according to court documents filed this week. The Warsaw, Ind.-based company and individuals involved in the multidistrict litigation told US District Judge Rebecca Pallmeyer this week that they’ve “reached a confidential settlement in principle that will potentially […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Stryker nears closure of Vexim takeover, passes 95% ownership
Stryker (NYSE:SYK) said today it has acquired approximately 95.5% of the share capital of French spinal implant maker Vexim, and that it plans to acquire the remaining shares soon. The Kalamazoo, Mich.-based company said that it has since crossed the 95% threshold and that it intends to file a proposed public buy-out offer and a squeeze-out for the remaining […]
Orthofix launches RCStim rotator cuff repair trial
Orthofix (NSDQ:OFIX) said today it launched a study looking to evaluate the use of pulsed electromagnetic field technology with the company’s RCStim device as adjunctive treatment to the surgical repair of rotator cuff tears. The 538-patient study, which has begun enrollment, will evaluate the safety and effectiveness of PEMF technology designed to promote bone growth and […]
Relievant touts 1-year Intracept trial results
Relievant Medsystems today released the results from the Smart trial of its Intracept intraosseous nerve ablation system exploring its usefulness at treating chronic lower back pain, touting significant decreases in pain from baseline at three months. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical […]
Zimmer Biomet loses bid to dismiss metal-on-metal hip cases
Zimmer Biomet (NYSE:ZBH) last Thursday lost two bids looking to dismiss claims in cases over alleged faults in metal-on-metal hips including an increased risk of metallosis, according to court documents. Motions for summary judgement related to the Taper, ReCap and metal-on-polyethylene devices and motions for summary judgement relating to state-of-the-art defense were denied by US District […]
Simplify Medical closes $23m in 2nd tranche of Series B
Simplify Medical said today it closed $23.3 million as part of the second tranche of its oversubscribed Series B financing, which brought in a total of $44.3 million for the company and its namesake cervical disc replacement. The Sunnyvale, Calif.-based company’s Simplify disc is designed to be magnetic resonance imaging safe and to eliminate imaging artifacts […]
Smith & Nephew looks to $160m cost-cutting as 2017 earnings top estimates
Perhaps seeking to stave off a hedge fund’s carveout push, Smith & Nephew (NYSE:SNN) today revealed a cost-cutting program it hopes will pare $160 million from its annual operating budget and posted 2017 results that beat earnings expectations. Last year Elliott Management took out a stake in the British orthopedic and wound care firm, leading to […]
Anika collabs to develop injectable stem cell therapy for osteoarthritis
Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis. As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials. Get the full story at our […]
Finland’s BBS-Bioactive Bone Substitute plans $10m IPO
BBS-Bioactive Bone Substitutes said today that’s its planning for an initial public offering later this year it hopes will bring in some $10 million. Oulu, Finland-based BBS said it plans to list 1.5 million shares at €5.50 apiece beginning Feb. 5 for gross proceeds of €7.7 million, or roughly $9.6 million. The shares, due to trade […]
Judge grants class certification in lawsuit over Medtronic’s Infuse
A federal judge in Minnesota yesterday granted class certification to an investors’ lawsuit brought against Medtronic (NYSE:MDT) over its Infuse bone-growth protein, a little more than a year after an appeals court revived the case. Approved in 2002 for use in spinal fusion surgery, Infuse at one point had annual sales of nearly $1 billion. The […]
Zimmer Biomet’s profits surge on tax gain
The tax reforms enacted last year created huge fourth-quarter and full-year profit gains for Zimmer Biomet (NYSE:ZBH), but the orthopedics giant still only managed to meet Wall Street’s earnings expectations despite logging sales beats for both periods. Warsaw, Ind.-based Zimmer Biomet posted profits of $1.26 billion, or $6.16 per share, on sales of $2.07 billion for […]